Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 5085-5088, October 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soldatenkov, V. A.
Right arrow Articles by Fuchs, S. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soldatenkov, V. A.
Right arrow Articles by Fuchs, S. Y.
[Cancer Research 59, 5085-5088, October 15, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Inhibition of Homologue of Slimb (HOS) Function Sensitizes Human Melanoma Cells for Apoptosis1

Viatcheslav A. Soldatenkov, Anatoly Dritschilo, Ze’ev Ronai and Serge Y. Fuchs2

Department of Radiation Medicine, Lombardi Cancer Center, Georgetown University Medical Center, Washington, D.C. 20007 [V. A. S., A. D.], and The Ruttenberg Cancer Center, Mount Sinai School of Medicine, New York, New York 10029 [Z. R., S. Y. F.]

Homologue of Slimb (HOS)/{beta}-transducin repeats containing proteins up-regulate nuclear factor {kappa}B activity by targeting its inhibitor (I{kappa}B) for ubiquitination and subsequent degradation. We investigated whether inhibition of HOS function may modulate apoptosis in human melanoma cells. Forced expression of the dominant negative HOS{Delta}F construct inhibited I{kappa}B degradation and led to sensitization of melanoma cells to apoptosis induced by tumor necrosis factor {alpha} with cycloheximide, as well as by cisplatin and ionizing and UV irradiation. These data indicate that HOS plays an important role in controlling the I{kappa}B-dependent apoptotic pathways in human melanoma.




This article has been cited by other articles:


Home page
Cancer Res.Home page
W. Tang, Y. Li, D. Yu, A. Thomas-Tikhonenko, V. S. Spiegelman, and S. Y. Fuchs
Targeting {beta}-Transducin Repeat-Containing Protein E3 Ubiquitin Ligase Augments the Effects of Antitumor Drugs on Breast Cancer Cells
Cancer Res., March 1, 2005; 65(5): 1904 - 1908.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. Ougolkov, B. Zhang, K. Yamashita, V. Bilim, M. Mai, S. Y. Fuchs, and T. Minamoto
Associations Among {beta}-TrCP, an E3 Ubiquitin Ligase Receptor, {beta}-Catenin, and NF-{kappa}B in Colorectal Cancer
J Natl Cancer Inst, August 4, 2004; 96(15): 1161 - 1170.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Li, S. Gazdoiu, Z.-Q. Pan, and S. Y. Fuchs
Stability of Homologue of Slimb F-box Protein Is Regulated by Availability of Its Substrate
J. Biol. Chem., March 19, 2004; 279(12): 11074 - 11080.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. S. Spiegelman, W. Tang, A. M. Chan, M. Igarashi, S. A. Aaronson, D. A. Sassoon, M. Katoh, T. J. Slaga, and S. Y. Fuchs
Induction of Homologue of Slimb Ubiquitin Ligase Receptor by Mitogen Signaling
J. Biol. Chem., September 20, 2002; 277(39): 36624 - 36630.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Bhoumik, V. Ivanov, and Z.'e. Ronai
Activating Transcription Factor 2-derived Peptides Alter Resistance of Human Tumor Cell Lines to Ultraviolet Irradiation and Chemical Treatment
Clin. Cancer Res., February 1, 2001; 7(2): 331 - 342.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
O. Salvucci, M. Carsana, I. Bersani, G. Tragni, and A. Anichini
Antiapoptotic Role of Endogenous Nitric Oxide in Human Melanoma Cells
Cancer Res., January 1, 2001; 61(1): 318 - 326.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.